Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis

Front Immunol. 2023 Oct 25:14:1288169. doi: 10.3389/fimmu.2023.1288169. eCollection 2023.

Abstract

Introduction: The immunoglobulin kappa free light chain (KFLC) index has been proposed as a potentially suitable alternative to oligoclonal IgG bands (OCGB) for diagnosing multiple sclerosis (MS), offering automation and reduced processing time. However, there is no consensus on the preferred approach or how to combine both techniques.

Methods: This prospective cohort study aimed to determine the best utilization of OCGB and KFLC index in patients with a clinically isolated syndrome (CIS) followed for at least two years. OCGB and KFLC were assessed using isoelectric focusing and immunoblotting and turbidimetry, respectively. Sensitivity, specificity, and accuracy for diagnosing MS were calculated for each method.

Results: The study included 371 patients, with 260 (70.1 %) being women, and a median age of 34.9 (27.8 - 43.9) years. Using a cut-off value of 6.1, the KFLC index demonstrated a sensitivity and specificity of 86.3% and 93.9%, respectively. The sensitivity of OCGB (95.3%) was higher (p < 0.001 vs. KFLC index) and the specificity (100%) was comparable to that of the KFLC index (p = 0.5). The concordance between the methods was not uniform across all patients, with 97.8% agreement in patients with KFLC index ≥ 6.1 and 56.0 % in patients with KFLC index < 6.1. In patients with a KFLC index < 6.1, OCGB still identified 75.0 % of MS patients due to its higher sensitivity. An algorithm using the KFLC index as a screening tool and OCGB as an alternative for patients with a negative KFLC index result achieved an accuracy of 96.3 %.

Discussion: Combining the KFLC index and OCGB can provide an easily reproducible and accurate method for diagnosing MS, with OCGB primarily reserved for patients with a KFLC index < 6.1.

Keywords: clinically isolated syndrome; diagnosis; kappa free light chain; multiple sclerosis; oligoclonal bands.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Humans
  • Immunoglobulin Light Chains
  • Immunoglobulin kappa-Chains
  • Male
  • Multiple Sclerosis* / diagnosis
  • Oligoclonal Bands
  • Prospective Studies

Substances

  • Oligoclonal Bands
  • Immunoglobulin kappa-Chains
  • Immunoglobulin Light Chains

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants PI21/00828 (Fondo de Investigación Sanitaria) and RD21/0002/0053 (Redes de Investigación Cooperativa Orientadas a Resultados en Salud) from the Instituto de Salud Carlos III. Ministerio de Ciencia e Innovación. Spain and FEDER: “Una manera de hacer Europa.”. The fellowships of José Ignacio Fernández-Velasco, PhD, and Raquel Sainz-Amo, MD, were supported by a Río Hortega grant (CM20/00131 and CM22/00163, respectively).